Exact Sciences (EXAS) Total Current Liabilities (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Total Current Liabilities data on file, last reported at $641.2 million in Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $641.2 million, down 12.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $641.2 million (down 12.43% YoY), and the FY2025 annual result was $641.2 million, down 12.43% from the prior year.
• Total Current Liabilities improved to $641.2 million in Q4 2025 per EXAS's latest filing, from $584.3 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $732.2 million in Q4 2024 and troughed at $367.4 million in Q1 2023.
• A 5-year average of $559.9 million and a median of $519.5 million in 2021 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2021 and 2022: Total Current Liabilities surged 203.99% in 2021, then sank 40.35% in 2022.
• A 5-year view of Total Current Liabilities shows it stood at $517.1 million in 2021, then decreased by 20.18% to $412.7 million in 2022, then increased by 24.7% to $514.7 million in 2023, then jumped by 42.25% to $732.2 million in 2024, then decreased by 12.43% to $641.2 million in 2025.
• Business Quant data shows EXAS's Total Current Liabilities at $641.2 million in Q4 2025, $584.3 million in Q3 2025, and $521.9 million in Q2 2025.